Earnings Per Share (EPS) is anticipated to be $1.38, marking a 4.6% increase from the previous year.
Revenue is expected to reach approximately $292 million, reflecting a 5.7% year-over-year growth.
The company boasts a price-to-earnings (P/E) ratio of 27.19 and a low debt-to-equity ratio of 0.05, indicating minimal reliance on debt.
Addus HomeCare Corporation, trading under the symbol ADUS on the NASDAQ, is a prominent player in the home healthcare services industry. The company provides a range of services, including personal care, hospice, and home health services. As it prepares to release its quarterly earnings on February 24, 2025, Wall Street anticipates an earnings per share (EPS) of $1.35 and revenue of approximately $291 million.
However, recent projections suggest a slightly higher EPS of $1.38, marking a 4.6% increase from the previous year. Revenue is also expected to be slightly higher at $292 million, reflecting a 5.7% year-over-year growth. This upward revision in EPS by 0.6% over the past 30 days indicates a positive reassessment by analysts, which could influence short-term stock price movements.
Addus HomeCare’s financial metrics provide further insights into its market position. The company has a price-to-earnings (P/E) ratio of 27.19, indicating the price investors are willing to pay for each dollar of earnings. Its price-to-sales ratio is 1.79, suggesting the company’s market value relative to its sales. The enterprise value to sales ratio stands at 1.64, reflecting the company’s total value compared to its sales.
The enterprise value to operating cash flow ratio is 13.66, showing the company’s valuation in relation to its cash flow from operations. The earnings yield is 3.68%, representing the return on investment for shareholders. Addus HomeCare maintains a conservative capital structure with a low debt-to-equity ratio of 0.05, indicating minimal reliance on debt. Additionally, the current ratio of 2.11 suggests a strong ability to cover short-term liabilities with short-term assets.
